Max Schlueter

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 7

Top Topics

Systematic Review

Replacement Therapy

Angiotensin Converting Enzyme

Polycyclic Aromatic Hydrocarbons

Top Venues

Journal of comparative effectiveness research

BMC pulmonary medicine

The European journal of health economics : HEPAC : health economics in prevention and care

This page only lists publications with an associated author ORCID identifier.

Publications

Max Schlueter, Sandra Nestler-Parr
Letter to the editor: network meta-analysis for indirect comparison of lanadelumab and for the treatment of hereditary angioedema. Journal of comparative effectiveness research (2024)
Max Schlueter, Sandra Nestler-Parr
Letter to the editor: network meta-analysis for indirect comparison of lanadelumab and berotralstat for the treatment of hereditary angioedema. Journal of comparative effectiveness research 13 (5) (2024)
Max Schlueter, Sandra Nestler-Parr
Letter to the editor: network meta-analysis for indirect comparison of lanadelumab and berotralstat for the treatment of hereditary angioedema. Journal of comparative effectiveness research 13 (5) (2024)
Max Schlueter, Sandra Nestler-Parr
Letter to the editor: network meta-analysis for indirect comparison of lanadelumab and berotralstat for the treatment of hereditary angioedema. Journal of comparative effectiveness research 13 (5) (2024)
Max Schlueter, Sandra Nestler-Parr
Letter to the editor: network meta-analysis for indirect comparison of lanadelumab and berotralstat for the treatment of hereditary angioedema. Journal of comparative effectiveness research 13 (5) (2024)
Jean-Baptiste Trouiller, Georgios F Nikolaidis, Bérengère Macabeo, Nicolas Meyer, Laetitia Gerlier, Max Schlueter, Philippe Laramee
Cost-effectiveness of encorafenib with binimetinib in unresectable or metastatic BRAF-mutant melanoma. The European journal of health economics : HEPAC : health economics in prevention and care (2023)
Max Schlueter, Amélie Beaudet, Evan Davies, Binu Gurung, Andreas Karabis
Evidence synthesis in pulmonary arterial hypertension: a systematic review and critical appraisal. BMC pulmonary medicine 20 (1) (2020)